283 related articles for article (PubMed ID: 29326883)
1. Metabolic Plasiticy in Cancers-Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs.
Ždralević M; Marchiq I; de Padua MMC; Parks SK; Pouysségur J
Front Oncol; 2017; 7():313. PubMed ID: 29326883
[TBL] [Abstract][Full Text] [Related]
2. Disrupting the 'Warburg effect' re-routes cancer cells to OXPHOS offering a vulnerability point via 'ferroptosis'-induced cell death.
Ždralević M; Vučetić M; Daher B; Marchiq I; Parks SK; Pouysségur J
Adv Biol Regul; 2018 May; 68():55-63. PubMed ID: 29306548
[TBL] [Abstract][Full Text] [Related]
3. Whole-transcriptome Analysis of Fully Viable Energy Efficient Glycolytic-null Cancer Cells Established by Double Genetic Knockout of Lactate Dehydrogenase A/B or Glucose-6-Phosphate Isomerase.
Mazzio E; Badisa R; Mack N; Cassim S; Zdralevic M; Pouyssegur J; Soliman KFA
Cancer Genomics Proteomics; 2020; 17(5):469-497. PubMed ID: 32859627
[TBL] [Abstract][Full Text] [Related]
4. Disrupting glucose-6-phosphate isomerase fully suppresses the "Warburg effect" and activates OXPHOS with minimal impact on tumor growth except in hypoxia.
de Padua MC; Delodi G; Vučetić M; Durivault J; Vial V; Bayer P; Noleto GR; Mazure NM; Ždralević M; Pouysségur J
Oncotarget; 2017 Oct; 8(50):87623-87637. PubMed ID: 29152106
[TBL] [Abstract][Full Text] [Related]
5. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
6. Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential.
Sun X; Wang M; Wang M; Yao L; Li X; Dong H; Li M; Sun T; Liu X; Liu Y; Xu Y
Front Cell Dev Biol; 2020; 8():651. PubMed ID: 32766253
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
8. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis.
Dhup S; Dadhich RK; Porporato PE; Sonveaux P
Curr Pharm Des; 2012; 18(10):1319-30. PubMed ID: 22360558
[TBL] [Abstract][Full Text] [Related]
9. Separation of metabolic supply and demand: aerobic glycolysis as a normal physiological response to fluctuating energetic demands in the membrane.
Epstein T; Xu L; Gillies RJ; Gatenby RA
Cancer Metab; 2014; 2():7. PubMed ID: 24982758
[TBL] [Abstract][Full Text] [Related]
10. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic virus-induced aerobic glycolysis and tumorigenesis.
Yu L; Chen X; Wang L; Chen S
J Cancer; 2018; 9(20):3699-3706. PubMed ID: 30405839
[TBL] [Abstract][Full Text] [Related]
12. Tumor glycolysis, an essential sweet tooth of tumor cells.
Paul S; Ghosh S; Kumar S
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1216-1230. PubMed ID: 36330953
[TBL] [Abstract][Full Text] [Related]
13. Human haptoglobin contributes to breast cancer oncogenesis through glycolytic activity modulation.
Chen J; Cheuk IW; Siu MT; Yang W; Cheng AS; Shin VY; Kwong A
Am J Cancer Res; 2020; 10(9):2865-2877. PubMed ID: 33042622
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.
Feron O
Radiother Oncol; 2009 Sep; 92(3):329-33. PubMed ID: 19604589
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth.
Mathew M; Nguyen NT; Bhutia YD; Sivaprakasam S; Ganapathy V
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339256
[TBL] [Abstract][Full Text] [Related]
16. Modeling cancer glycolysis under hypoglycemia, and the role played by the differential expression of glycolytic isoforms.
Marín-Hernández A; López-Ramírez SY; Del Mazo-Monsalvo I; Gallardo-Pérez JC; Rodríguez-Enríquez S; Moreno-Sánchez R; Saavedra E
FEBS J; 2014 Aug; 281(15):3325-45. PubMed ID: 24912776
[TBL] [Abstract][Full Text] [Related]
17. Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer.
Cassim S; Vučetić M; Ždralević M; Pouyssegur J
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365833
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
19. Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches.
de la Cruz-López KG; Castro-Muñoz LJ; Reyes-Hernández DO; García-Carrancá A; Manzo-Merino J
Front Oncol; 2019; 9():1143. PubMed ID: 31737570
[TBL] [Abstract][Full Text] [Related]
20. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
